nikhil hutheesing

Face-Off on Stocks: Tiffany, Coach and Polo Ralph Lauren

Luxury retailers tend to be early cycle stocks: They move in advance of other sectors. Shares in Tiffany, Coach and Polo Ralph Lauren have been been crushing the broader market for a while. But will they continue? Do their stocks make good buys? Watch Face-Off.

Face-Off on Stocks: Barrick Gold, Newmont Mining, Goldcorp

With gold prices going gangbusters, there's no shortage of ways to play the precious metal. But if you're really looking for some action (as well as some potential downside protection), individual gold-mining picks have the best shot to outperform.

Where Were You When Lehman Brothers Collapsed?

From the floor of the New York Stock Exchange to the cubicles and boardrooms of New York's biggest banks, when Lehman Brothers failed, it was clear that the rules had suddenly changed. Here are some recollections of that day in September, 2008.

Face-Off on Stocks: Bank of America, JPMorgan Chase, Citigroup

The implosion of Lehman Brothers was just two years ago and yet Wall Street and the financial industry are still struggling to rebuild from the ashes. But as the economy recovers, are bank stocks good buys? Here are the bull and bear cases for three of the nation's biggest banks.

The Bulls Lead the Charge
Into September

A better-than-expected reading on the job market propelled stocks to their fourth straight day of gains, putting a bullish stamp on the first few days of September trading after the worst month of August for U.S. equities in nearly a decade.

Seven Reasons Not to Buy a Home

Nobody should ever consider owning a home. One of the biggest scams perpetrated on the American public is that owning a home is the "American Dream." It's more nightmare than dream as now millions of Americans know. But it has always been that way. Here's why.

Biotech Stocks With Upside Potential

Hilary Kramer recently recommended shares of Jazz Pharmaceuticals, which surged 16% on Wednesday before closing up just 3%. The reason: The U.S. Food and Drug Administration approved the drug, used for narcolepsy, for fibromyalgia.Kramer also recommends two other biotech medical equipment companies with upside potential.

Face-Off on Stocks: HP, Cisco and Intel

Tech stocks are on sale these days, giving buyers a chance to pick up shares at impressive discounts. The sale isn't due entirely to market jitters. A good sex scandal helped to create opportunity as did less than rosy earnings forecasts.

Seven Reasons Not to Send Your Kids to College

Is investing in a college education money wasted? James Altucher, managing director of Formula Capital, says it is. In this video interview, Altucher argues that there are far better ways to put your money to work to benefit your kids. Controversial? You bet, but his ideas are certainly food for thought.

James Altucher: Gold Is Just a Rock. Buy Stocks

With the price of gold now off its highs, should investors put money into the precious metal? James Altucher explains why there are better places to invest in this short and frank discussion on silver, gold and stocks.

Face-Off: Energizer, P&G, Spectrum Brands

Hot summer weather got us thinking about short summer haircuts, which is as good a way as any to take a closer look at some consumer staples stocks. Save for utilities, no other sector has held up as well in a down market.

How to Profit From a Rebound in Housing Stocks

Despite the volatility in the stock market, there are signs that the economy is getting stronger. Good news for the housing market. Hilary Kramer, editor of GameChangerStocks.com, explains how you can profit.

Face-Off on Stocks: Google, Apple and Ford

As the markets swoon, DailyFinance's Nikhil Hutheesing and Dan Burrows face-off in just over 4 minutes about the future direction of the economy and discuss the future of stocks.